These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32379777)
21. Perinatal outcomes and the use of oral hypoglycemic agents. Bertini AM; Silva JC; Taborda W; Becker F; Lemos Bebber FR; Zucco Viesi JM; Aquim G; Engel Ribeiro T J Perinat Med; 2005; 33(6):519-23. PubMed ID: 16318615 [TBL] [Abstract][Full Text] [Related]
22. Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy? Homko CJ; Sivan E; Reece AE Treat Endocrinol; 2004; 3(3):133-9. PubMed ID: 16026109 [TBL] [Abstract][Full Text] [Related]
23. Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure. Affres H; Senat MV; Letourneau A; Deruelle P; Coustols-Valat M; Bouchghoul H; Bouyer J Diabetes Metab; 2021 Jul; 47(4):101210. PubMed ID: 33249198 [TBL] [Abstract][Full Text] [Related]
24. Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent? Brustman L; Langer O; Scarpelli S; El Daouk M; Fuchs A; Rosenn B Obstet Gynecol; 2011 Feb; 117(2 Pt 1):349-353. PubMed ID: 21252749 [TBL] [Abstract][Full Text] [Related]
25. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Hebert MF; Ma X; Naraharisetti SB; Krudys KM; Umans JG; Hankins GD; Caritis SN; Miodovnik M; Mattison DR; Unadkat JD; Kelly EJ; Blough D; Cobelli C; Ahmed MS; Snodgrass WR; Carr DB; Easterling TR; Vicini P; Clin Pharmacol Ther; 2009 Jun; 85(6):607-14. PubMed ID: 19295505 [TBL] [Abstract][Full Text] [Related]
26. Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis. Yu DQ; Xu GX; Teng XY; Xu JW; Tang LF; Feng C; Rao JP; Jin M; Wang LQ BMC Endocr Disord; 2021 Oct; 21(1):199. PubMed ID: 34641848 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological therapy in gestational diabetes - a comparison between insulin and oral therapy. Shmuel E; Krispin E; Toledano Y; Chen R; Wiznitzer A; Hadar E J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5071-5079. PubMed ID: 33461358 [TBL] [Abstract][Full Text] [Related]
28. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069 [TBL] [Abstract][Full Text] [Related]
29. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Yogev Y; Ben-Haroush A; Chen R; Rosenn B; Hod M; Langer O Obstet Gynecol; 2004 Jul; 104(1):88-93. PubMed ID: 15229005 [TBL] [Abstract][Full Text] [Related]
30. Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? A systematic review and meta-analysis. Helal KF; Badr MS; Rafeek ME; Elnagar WM; Lashin ME Arch Gynecol Obstet; 2020 Jan; 301(1):19-32. PubMed ID: 31989292 [TBL] [Abstract][Full Text] [Related]
31. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Zeng YC; Li MJ; Chen Y; Jiang L; Wang SM; Mo XL; Li BY Adv Med Sci; 2014 Mar; 59(1):95-101. PubMed ID: 24797983 [TBL] [Abstract][Full Text] [Related]
32. Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes. Hedderson MM; Badon SE; Pimentel N; Xu F; Regenstein A; Ferrara A; Neugebauer R JAMA Netw Open; 2022 Mar; 5(3):e225026. PubMed ID: 35357451 [TBL] [Abstract][Full Text] [Related]
33. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. Balsells M; García-Patterson A; Solà I; Roqué M; Gich I; Corcoy R BMJ; 2015 Jan; 350():h102. PubMed ID: 25609400 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: A Bayesian network analysis of randomized controlled trials. Wang T; Jing Y; Guo H; Xu J; Wang M; Huang L; Chen H; Cui W; Song L; Liu X; Sun B; Wang N Front Public Health; 2022; 10():980578. PubMed ID: 36530712 [TBL] [Abstract][Full Text] [Related]
36. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Nachum Z; Zafran N; Salim R; Hissin N; Hasanein J; Gam Ze Letova Y; Suleiman A; Yefet E Diabetes Care; 2017 Mar; 40(3):332-337. PubMed ID: 28077460 [TBL] [Abstract][Full Text] [Related]
37. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Kraemer J; Klein J; Lubetsky A; Koren G Am J Obstet Gynecol; 2006 Jul; 195(1):270-4. PubMed ID: 16579925 [TBL] [Abstract][Full Text] [Related]
38. Glyburide in Women With Mild Gestational Diabetes: A Randomized Controlled Trial. Casey BM; Duryea EL; Abbassi-Ghanavati M; Tudela CM; Shivvers SA; McIntire DD; Leveno KJ Obstet Gynecol; 2015 Aug; 126(2):303-309. PubMed ID: 26241419 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. Malek R; Davis SN Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):691-9. PubMed ID: 27163280 [TBL] [Abstract][Full Text] [Related]
40. Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight. Díaz P; Dimasuay KG; Koele-Schmidt L; Jang B; Barbour LA; Jansson T; Powell TL Placenta; 2017 Sep; 57():52-59. PubMed ID: 28864019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]